RTI-113

CAS : 141807-57-0

Ref. TR-R701110

Informations sur le produit

• Nom: RTI-113
• Synonymes: (1R,2S,3S,5S)-3-(4-Chlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic Acid Phenyl Ester Hydrochloride, [1R-(exo,exo)]-3-(4-Chlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic Acid Phenyl Ester Hydrochloride, RTI 4229-113, 8-Azabicyclo[3.2.1]octane-2-carboxylic acid, 3-(4-chlorophenyl)-8-methyl-, phenyl ester, hydrochloride (1:1), (1R,2S,3S,5S)-, 8-Azabicyclo[3.2.1]octane-2-carboxylic acid, 3-(4-chlorophenyl)-8-methyl-, phenyl ester, hydrochloride, (1R,2S,3S,5S)-, 8-Azabicyclo[3.2.1]octane-2-carboxylic acid,3-(4-chlorophenyl)-8-methyl-, phenyl ester, hydrochloride, [1R-(exo,exo)]-, 8-Azabicyclo[3.2.1]octane-2-carboxylicacid, 3-(4-chlorophenyl)-8-methyl-, phenyl ester, hydrochloride, (1R,2S,3S,5S)-(9CI), Rti 113, Rti 4229-113, Rti113
• CAS: 141807-57-0

Description

Applications RTI-113 is a 3-phenyltropane analogue that acts as a potent and selective dopamine uptake inhibitor. RTI-113 has been shown to reduce cocaine self-administration at high occupancy of dopamine transporter. Studies suggest that RTI-113 and its analogs may be useful tools for developing potential agonist therapies for cocaine dependence.
References Dworkin, S. et al.: Synapse, 30, 49 (1998); Negus, S.S. et al.: Pharmacol. Biochem. Behav., 91, 333 (2009); Cook, C. et al.: Eur. J. Pharmacol., 442, 93 (2002);

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 392.32
• Formule: C₂₁H₂₃Cl₂NO₂
• Couleur/Forme: Neat
• InChI: InChI=1S/C21H22ClNO2.ClH/c1-23-16-11-12-19(23)20(21(24)25-17-5-3-2-4-6-17)18(13-16)14-7-9-15(22)10-8-14;/h2-10,16,18-20H,11-13H2,1H3;1H/t16-,18+,19+,20-;/m0./s1
• Code InChI: InChIKey=KVECWXYLPNBJOG-UHFFFAOYSA-N
• SMILES: CC(=O)OCC1CCC(=O)N1C(C)=O